Matches in Nanopublications for { ?s ?p "[In this study, the selective BTK inhibitor acalabrutinib had promising safety and efficacy profiles in patients with relapsed CLL, including those with chromosome 17p13.1 deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[In this study, the selective BTK inhibitor acalabrutinib had promising safety and efficacy profiles in patients with relapsed CLL, including those with chromosome 17p13.1 deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1295714.RAurLbiKfrFI7FB5fZLxRKSbHDbuyrOPD7LZoVcjMc6Es130_assertion description "[In this study, the selective BTK inhibitor acalabrutinib had promising safety and efficacy profiles in patients with relapsed CLL, including those with chromosome 17p13.1 deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295714.RAurLbiKfrFI7FB5fZLxRKSbHDbuyrOPD7LZoVcjMc6Es130_provenance.